The European Commission (EC) has approved Mylan N.V.'s $MYL reverse morris trust transaction with Pfizer's $PFE Off-Patent Business (Upjohn) with conditions, requiring that Mylan divest certain generic medicines that are produced within the European Economic Area (EEA) and the UK